Hinge Health, which completed its initial public offering in May 2025, has demonstrated substantial financial progress in its first year as a publicly traded company. The digital musculoskeletal health platform reported revenue growth of 51% to $587.9 million in 2025, while expanding its corporate client base by 25% year-over-year. The company's AI-powered physical therapy solutions are designed to help employers reduce overall healthcare expenditures by decreasing the need for surgical interventions.
The company's financial trajectory shows signs of operational improvement despite reporting a net loss for the full year 2025. Notably, Hinge Health achieved positive net income of $32 million in the fourth quarter and generated $61.5 million in free cash flow during the period. These metrics indicate the company is moving toward sustained profitability while maintaining its growth momentum.
Since its May 2025 debut, Hinge Health shares have appreciated 7% from their IPO price. Market analysts attribute the relatively modest share performance to potential investor underestimation of the company's profitability trajectory and the expanding addressable market within the corporate healthcare benefits sector.